Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 9:7:118.
doi: 10.3389/fphar.2016.00118. eCollection 2016.

β-Adrenoceptor-mediated Relaxation of Urinary Bladder Muscle in β2-Adrenoceptor Knockout Mice

Affiliations

β-Adrenoceptor-mediated Relaxation of Urinary Bladder Muscle in β2-Adrenoceptor Knockout Mice

Stefan Propping et al. Front Pharmacol. .

Abstract

Background and objective: In order to characterize the β-adrenoceptor (AR) subtypes involved in agonist-stimulated relaxation of murine urinary bladder we studied the effects of (-)-isoprenaline and CL 316,243 on tonic contraction and spontaneous contractions in detrusor strips of wild-type (WT) and β2-AR knockout (β2-AR KO) mice.

Materials and methods: Urinary bladders were isolated from male WT and β2-AR KO mice. β-AR subtype expression was determined with quantitative real-time PCR. Intact muscle strips pre-contracted with KCl (40 mM) were exposed to cumulatively increasing concentrations of (-)-isoprenaline or β3-AR agonist CL 316,243 in the presence and absence of the subtype-selective β-AR blockers CGP 20712A (β1-ARs), ICI 118,551 (β2-ARs), and L748,337 (β3-ARs).

Results: Quantitative real-time PCR confirmed lack of β2-AR expression in bladder tissue from β2-AR KO mice. In isolated detrusor strips, pre-contraction with KCl increased basal tone and enhanced spontaneous activity significantly more in β2-AR KO than in WT. (-)-Isoprenaline relaxed tonic tension and attenuated spontaneous activity with similar potency, but the concentrations required were two orders of magnitude higher in β2-AR KO than WT. The concentration-response curves (CRCs) for relaxation were not affected by CGP 20712A (300 nM), but were shifted to the right by ICI 118,551 (50 nM) and L748,337 (10 μM). The -logEC50 values for (-)-isoprenaline in WT and β2-AR KO tissue were 7.98 and 6.00, respectively, suggesting a large receptor reserve of β2-AR. (-)-CL 316,243 relaxed detrusor and attenuated spontaneous contractions from WT and β2-AR KO mice with a potency corresponding to the drug's affinity for β3-AR. L743,337 shifted the CRCs to the right.

Conclusion: Our findings in β2-AR KO mice suggest that there is a large receptor reserve for β2-AR in WT mice so that this β-AR subtype will mediate relaxation of tone and attenuation of spontaneous activity under physiological conditions. Nevertheless, upon removal of this reserve, β3-AR can also mediate murine detrusor relaxation.

Keywords: CL 316,243; detrusor muscle; isoprenaline; mucosa; relaxation; β2-adrenoceptor knockout; β3-adrenoceptors.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Expression of β-AR subtypes in urinary bladders und lungs of WT and β2-AR knockout mice. (A) Agarose gel electrophoresis of qualitative PCR of cDNA obtained from urinary bladder detrusor samples (left panel) and lung samples (right panel) of WT and β2-AR KO mice for β1-AR, β2-AR, β3-AR and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (B) mRNA expression of β1-AR, β2-AR, and β3-AR normalized to GAPDH in detrusor (WT, n = 3; β2-AR KO, n = 5). n represent numbers of mice measured in triplicates. Mean values ± SD.
FIGURE 2
FIGURE 2
Relaxation of KCl-precontracted intact detrusor strips from WT and β2-AR KO mice. (A) Original tracings of force of contraction (in mN) from two intact detrusor strips precontracted with KCl (40 mM) and subsequently relaxed with cumulatively increasing concentrations of (-)-isoprenaline. Forskolin (10 μM) was added at the end of each experiment. (B) Baseline amplitude (upper panel) and baseline integral (lower panel) of spontaneous activity before, and amplitudes and integrals after addition of KCl. (C) CRCs for the relaxing effects of (-)-isoprenaline on KCl-induced tone in detrusor strips from WT (open symbols) and β2-AR KO (closed symbols). Since tonic contraction was completely relaxed with 10 μM forskolin, the CRCs were normalized to the response with forskolin (= 100%). (D) CRCs for spontaneous activity expressed as force-time integral in percent of pre-agonist control for WT (open symbols) and β2-AR KO (closed symbols). A quantitative analysis of the data is shown in Table 1.
FIGURE 3
FIGURE 3
Effects β-AR blockers on detrusor tone and time-integral of spontaneous activity after exposure to 40 mM KCl (CGP, 300 nM CGP 20712A; ICI, 50 nM ICI 118,551; L748,337, 100 nM L748,337). (A,B) Peak increase (Fpeak) and steady-state increase in tone (Fss), respectively, after exposure to 40 mM KCl from WT and β2-AR KO preparations. Please note the difference in scale. (C,D) Time-integral of spontaneous contractions from WT and β2-AR KO preparations; baseline time-integral before (C) and time-integral after (D) exposure to 40 mM KCl. Mean ± SD from number of experiments as indicated. denotes P < 0.05 compared with control.
FIGURE 4
FIGURE 4
Effects of various β-AR subtype selective blockers on CRCs for (-)-isoprenaline-induced relaxation of KCl-induced tone (A–C) and spontaneous contractions (D–F) in detrusor strips from WT (open symbols) and β2-AR KO mice (closed symbols). CRCs were performed in the presence of the β1-AR-selective blocker CGP 20712A (A,D), the β2-AR-selective blocker ICI 118,551 (B,E), the β3-AR-selective blocker L748,337 (C,F). The respective controls (WT, dashed gray lines; β2-AR KO, continuous gray lines) were taken from the same experiments as in Figure 2. Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals).
FIGURE 5
FIGURE 5
Effects of the β3-AR-selective blocker L748,337, 1 μM (A), 3 μM (B), and 10 μM (C), on CRCs for (-)-isoprenaline-induced relaxation of KCl-precontracted detrusor strips from WT mice. The control is taken from the same experiments as in Figure 2. Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals). (D) Schild plot for determining the pA2 value of L748,337 (see Materials and Methods for further details).
FIGURE 6
FIGURE 6
Relaxation in response to the β3-AR-selective agonist CL 316.243 of KCl-pre-contracted detrusor strips from wild type (WT) and β2-AR KO mice. (A) Original tracings of force of contraction (in mN) from two detrusor strips precontracted with KCl (40 mM) and subsequently relaxed with cumulatively increasing concentrations of CL 316,243. At the end of each experiment complete relaxation was induced with forskolin (10 μM) as indicated. (B) Amplitude (upper panel) and integral (lower panel) of spontaneous activity before and after addition of KCl. (C,D) CRCs for the CL 316,243 effects on tone and spontaneous activity in WT and β2-AR KO, respectively. Similar lay-out as in Figure 2.
FIGURE 7
FIGURE 7
Effects of various concentrations of the β3-AR-selective blocker L748,337 on CRCs for the tone relaxing effects of CL 316,243 in KCl-precontracted detrusor strips from WT (A) and β2-AR KO mice (B). Control data (WT, dashed gray lines; β2-AR KO, continuous gray lines) were taken from Figure 2. (C) Schild plot for determining the pA2 value of L748,337 in β2-AR KO (see Materials and Methods for further details). Please note that no Schild plot could be obtained for data from WT. Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals).
FIGURE 8
FIGURE 8
Concentration-response curves for the relaxing effects of forskolin on KCl-induced contractions in detrusor strips from WT and β2-AR KO mice. (A) Forskolin effects on tone; effects on spontaneous contractions (B). Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals).

Similar articles

Cited by

References

    1. Andersson K. E., Arner A. (2004). Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84 935–986. 10.1152/physrev.00038.2003 - DOI - PubMed
    1. Blin N., Nahmias C., Drumare M. F., Strosberg A. D. (1994). Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor. Br. J. Pharmacol. 112 911–919. 10.1111/j.1476-5381.1994.tb13167.x - DOI - PMC - PubMed
    1. Cernecka H., Sand C., Michel M. C. (2014). The odd sibling: features of beta3-adrenoceptor pharmacology. Mol. Pharmacol. 86 479–484. 10.1124/mol.114.092817 - DOI - PubMed
    1. Chapple C. R., Cardozo L., Nitti V. W., Siddiqui E., Michel M. C. (2014). Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol. Urodyn. 33 17–30. 10.1002/nau.22505 - DOI - PubMed
    1. Chernogubova E., Hutchinson D. S., Nedergaard J., Bengtsson T. (2005). Alpha1- and beta1-adrenoceptor signaling fully compensates for beta3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Endocrinology 146 2271–2284. 10.1210/en.2004-1104 - DOI - PubMed